Diversified Consumer Services
Company Overview of The University of Pennsylvania
University of Pennsylvania is an educational institution offering graduate, undergraduate, professional, summer courses, and distance learning programs in fields such as law, medicines, communication, and dental medicine. The schools of the university include School of Arts and Sciences; Annenberg School for Communication; School of Dental Medicine; Graduate School of Education; School of Engineering and Applied Science; Graduate School of Fine Arts; Law School; School of Medicine; School of Nursing; School of Social Work; School of Veterinary Medicine; and Wharton School. University of Pennsylvania was established in 1740 and is based in Philadelphia, Pennsylvania. The university has endowm...
3451 Walnut Street
Philadelphia, PA 19104
Founded in 1740
Key Executives for The University of Pennsylvania
Dean of the School of Design
Associate, Licensing and New Business Start-Up at Center for Technology Transfer
Compensation as of Fiscal Year 2014.
The University of Pennsylvania Key Developments
Juno Therapeutics Resolves Litigation with University of Pennsylvania and Novartis Pharmaceuticals
Apr 6 15
Juno Therapeutics reached a settlement agreement to resolve litigation with the Trustees of the University of Pennsylvania and Novartis Pharmaceuticals, under which Novartis will make payments an initial payment of $12.3 million to Juno in addition to future milestone payments. Also under the agreement, Novartis will pay Juno mid-single digit royalties from U.S. net sales of product candidates related to the disputed contract and patent claims, as well as a low double-digit percentage of the royalties Novartis pays to the University of Pennsylvania for global net sales for the product candidates. Juno noted it became a party to the litigation after it entered into a December 2013 license agreement with St. Jude Children's Research Hospital, also a party in the litigation, for patent rights owned by St. Jude. The litigation began in July 2012 in connection with a contract dispute between St. Jude and Penn, and was broadened in March 2013 to include a dispute concerning a St. Jude's U.S. Patent titled Chimeric Receptors with 4-1BB Stimulatory Signaling Domain. Payments received by Juno will be shared with St. Jude under the terms of the license agreement between Juno and St. Jude. The parties also agreed to dismiss all claims in the relevant legal proceedings.
University of Pennsylvania and the Wharton School Launch Penn Wharton China Center
Mar 10 15
The University of Pennsylvania and the Wharton School of the University of Pennsylvania announced the opening of the Penn Wharton China Center in Beijing, China. The Center is an important expansion of Penn's engagement with China, which began in 1896 when the first Chinese student enrolled at Penn. It will operate through the University's China based affiliate, Penn Wharton Consulting (Beijing) Co, LTD. The Center will serve as a valuable resource and vibrant gathering place enhancing learning and research opportunities to the benefit of Penn's faculty, students, alumni and friends in China. Through its consulting programs, it will also support Chinese executives and others in acquiring the practical skills and perspectives that will help them successfully lead their organizations in a global context. To celebrate the opening, Provost Price will lead a delegation of more than 40 faculty and senior administrators from Penn that includes Vice Provost for Global Initiatives Ezekiel Emanuel, Dean of the Wharton School Geoffrey Garrett and seven other Penn deans. They are convening a two-day series of academic discussions this month featuring a roundtable with Chinese university leaders to discuss issues in higher education, panel discussions with senior Chinese business leaders and Penn scholars, and research talks with Penn faculty and deans.
University of Pennsylvania and University of Georgia Scientists Wins New Contract from the National Institutes of Allergy and Infectious Disease
Dec 18 14
A genome database team led by University of Pennsylvania and University of Georgia scientists has been awarded a new contract from the National Institutes of Allergy and Infectious Disease worth $4.3 million in 2014 to 2015. Assuming annual renewal, this five-year award is expected to total $23.4 million. The team has been responsible for developing genome database resources for microbial pathogens, including the parasites responsible for malaria, sleeping sickness, toxoplasmosis and many other important diseases. The new contract ensures work will continue on the Eukaryotic Pathogen Genomics Database known as EuPathDB to provide the global scientific community with free access to a wealth of genomic data related to microbial pathogens important to human health and bio-security. EuPathDB expedites biomedical research in the lab, field and clinic, enabling the development of innovative diagnostics, therapies and vaccines. The latest contract is the third time that NIH has awarded support to EuPathDB, building on previous contracts issued in 2004 and 2009 as well as prior grant funding from the NIH and the Burroughs Wellcome Fund.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|